## Remifentanil vs Morphine: Metabolism in Organ Dysfunction ### The Unique Advantage of Remifentanil **Key Point:** Remifentanil is metabolized by non-specific plasma and tissue esterases, NOT by the liver or kidneys. This makes it the ideal opioid in patients with hepatic or renal dysfunction. ### Comparative Pharmacokinetics | Feature | Remifentanil | Morphine | |---------|--------------|----------| | **Metabolism** | Plasma esterases (ester hydrolysis) | Hepatic glucuronidation | | **Organ dependence** | None (independent of liver/kidney) | Hepatic + renal (active metabolites) | | **Elimination half-life** | 10–20 minutes | 2–3 hours | | **Context-sensitive half-time** | 3–5 minutes (constant, regardless of infusion duration) | Increases with duration | | **Metabolite activity** | Inactive (remifentanil acid) | Active (M6G, M3G) | | **Dosing in liver disease** | No adjustment needed | Reduce dose; increase interval | | **Dosing in renal disease** | No adjustment needed | Reduce dose; increase interval | ### Why Remifentanil is Superior in Cirrhosis **High-Yield:** Remifentanil's ester metabolism is rapid and occurs in blood and tissues via non-specific esterases. This pathway is NOT impaired by hepatic dysfunction, renal failure, or pseudocholinesterase deficiency (except in severe deficiency). **Clinical Pearl:** In a cirrhotic patient like the one in this stem: - Morphine would accumulate due to impaired hepatic metabolism and renal clearance of M6G. - Remifentanil provides predictable, rapid offset regardless of liver function, allowing precise titration and rapid emergence from anesthesia. - Remifentanil is the **opioid of choice in hepatic failure, renal failure, and critical illness**. **Mnemonic:** **ESTER = Eliminated Safely, Tissue Esterases, Reliable** — remifentanil's ester bond is cleaved by ubiquitous plasma and tissue esterases, making it organ-independent. ### Clinical Implications 1. **No dose adjustment** needed in liver or kidney disease. 2. **Rapid offset** (3–5 min context-sensitive half-time) allows quick reversal if respiratory depression occurs. 3. **Predictable pharmacokinetics** even in severe organ dysfunction. 4. **Ideal for ICU sedation** in multiorgan failure. **Warning:** Remifentanil must be given as a continuous infusion (not bolus) due to its very short duration. Bolus dosing results in rapid offset and inadequate analgesia. [cite:KD Tripathi 8e Ch 31; Harrison 21e Ch 476]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.